Overview

The Effect of Liraglutide on Dietary Lipid Induced Insulin Resistance in Humans

Status:
Active, not recruiting
Trial end date:
2021-05-01
Target enrollment:
Participant gender:
Summary
In this research study, investigators will test the effects of an approved medication for diabetes,Liraglutide, to reduce insulin resistance that develops from eating a diet high in saturated fats.
Phase:
Phase 4
Details
Lead Sponsor:
Phoenix VA Health Care System
Collaborator:
Novo Nordisk A/S
Treatments:
Insulin
Liraglutide